내시경 협착 관리 기기 시장 : 제품, 용도, 최종 사용자별 - 세계 예측(2024-2032년)

Endoscopic Stricture Management Device Market size is projected to grow at 5.8% CAGR between 2024 and 2032. The rising prevalence of gastrointestinal disorders, such as Crohn's disease and esophageal strictures, is necessitating several effective treatment solutions. According to data from the National Library of Medicine, more than 7 million people in Europe and the U.S. will be suffering from inflammatory bowel diseases (IBD) by 2030. Significant advancements in endoscopy are enhancing the precision, efficacy, and safety of stricture management, leading to increasing adoption rates.

The growing awareness and early diagnosis of gastrointestinal conditions is also spurring the demand for these devices. The aging global population, which is more prone to such disorders is also increasing the product deployment. Minimally invasive procedures offered by these devices to reduce recovery times and improve patient outcomes is also making them a preferred choice. The favorable regulatory approvals, increasing healthcare expenditure, and reimbursement policies are further driving the market growth.

The overall market is segregated into product, application, end-user, and region.

Based on product, the endoscopic stricture management device market from the balloon dilators segment will grow at notable pace between 2024 and 2032, on account of their effectiveness in treating strictures with minimal invasiveness. These devices offer precise dilation of narrowed areas in the gastrointestinal tract while reducing the need for surgery and enhancing patient recovery. Rapid advancements are improving their safety and efficacy. The increasing prevalence of gastrointestinal disorders and the rising awareness among healthcare professionals about advanced treatment options are fueling the product demand.

Endoscopic stricture management device industry from the colonic application segment is estimated to grow at significant rate up to 2032, led by the rising incidence of colorectal diseases, such as Crohn's disease and colorectal cancer. The increasing awareness and early diagnosis are driving the demand for effective treatment options. Technological developments in endoscopic devices are improving precision and patient outcomes. The rising preference for minimally invasive procedures and the growing aging population will further boost the segment growth.

Regionally, the Asia Pacific endoscopic stricture management device market will showcase strong gains between 2024 and 2032, driven by the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding access to advanced medical technologies. The growing awareness and early diagnosis of gastrointestinal conditions is boosting the demand for these devices in the region. The aging population and the increasing adoption of minimally invasive procedures will also push the regional industry progression.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Ongoing technological advances in endoscopic stricture management devices
    • 3.2.1.2 Increasing prevalence of diseases/disorders leading to strictures
    • 3.2.1.3 Increasing awareness towards early diagnosis of strictures
    • 3.2.1.4 Increase in minimally invasive surgical procedures using endoscopes
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory requirements for device approval
    • 3.2.2.2 High cost of endoscopic surgical procedures using balloon dilation and stents
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Million)

• 5.1 Key trends
• 5.2 Stents
  • 5.2.1 Metal stents
  • 5.2.2 Plastic stents
  • 5.2.3 Biodegradable stents
• 5.3 Balloon dilators
  • 5.3.1 Balloon dilator catheters
  • 5.3.2 Balloon inflation devices
• 5.4 Bougie dilators
• 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

• 6.1 Key trends
• 6.2 Esophageal
• 6.3 Colonic
• 6.4 Pyloric
• 6.5 Biliary
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End User, 2021 - 2032 ($ Million)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgery centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Boston Scientific Corporation
• 9.2 Olympus Corporation
• 9.3 CONMED Corporation
• 9.4 Cook Medical Inc.
• 9.5 Becton, Dickinson and Company
• 9.6 Merit Medical Systems
• 9.7 Medi-Globe GmbH
• 9.8 PanMed Us
• 9.9 HOBBS MEDICAL, INC.
• 9.10 Micro-Tech (Nanjing) Co., Ltd
• 9.11 Steris plc (Diagmed Healthcare)
• 9.12 Taewoong Medical Co., Ltd.